Technology
New On Robinhood
Health
SI-BONE
$18.679876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$18.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.34 (-1.79%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell SI-BONE and other stocks, options, ETFs, and crypto commission-free!
About
SI-BONE, Inc. Common Stock, also called SI-BONE, is a medical device company, which engages in the research and development of minimally invasive surgical implant system. Read More Its product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA.
Employees
183
Headquarters
Santa Clara, California
Founded
2008
Market Cap
464.81M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
144.90K
High Today
$19.04
Low Today
$18.55
Open Price
$18.90
Volume
30.48K
52 Week High
$23.03
52 Week Low
$16.27
Collections
Technology
New On Robinhood
Health
Medical
2018 IPO
US
North America
News
Guru FocusMar 14
SI-BONE Inc (SIBN) Files 10-K for the Fiscal Year Ended on December 31, 2018
SI-BONE Inc (NASDAQ:SIBN) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. SI-BONE Inc has a market cap of $442.800 million; its shares were traded at around $18.11 . For the last quarter SI-BONE Inc reported a revenue of $15.6 million, compared with the revenue of $11.68 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $55.4 million, an increase of 15.4% from last year. The reported loss per diluted share was $2.2 for th...
Price Paid on Robinhood
3% Lower
Right Now
52 Week Low
$16.27
Average Price Paid
$19.17
52 Week High
$23.03
Earnings
-$0.30
-$0.27
-$0.24
-$0.21
Q3 2018
Q4 2018
Estimated
-$0.21 per share
Actual
-$0.22 per share